Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2008

Open Access 01-12-2008 | Research

Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity

Authors: Reddy M Pabbidi, Shuang-Quan Yu, Siying Peng, Romesh Khardori, Mary E Pauza, Louis S Premkumar

Published in: Molecular Pain | Issue 1/2008

Login to get access

Abstract

A common complication associated with diabetes is painful or painless diabetic peripheral neuropathy (DPN). The mechanisms and determinants responsible for these peripheral neuropathies are poorly understood. Using both streptozotocin (STZ)-induced and transgene-mediated murine models of type 1 diabetes (T1D), we demonstrate that Transient Receptor Potential Vanilloid 1 (TRPV1) expression varies with the neuropathic phenotype. We have found that both STZ- and transgene-mediated T1D are associated with two distinct phases of thermal pain sensitivity that parallel changes in TRPV1 as determined by paw withdrawal latency (PWL). An early phase of hyperalgesia and a late phase of hypoalgesia are evident. TRPV1-mediated whole cell currents are larger and smaller in dorsal root ganglion (DRG) neurons collected from hyperalgesic and hypoalgesic mice. Resiniferatoxin (RTX) binding, a measure of TRPV1 expression is increased and decreased in DRG and paw skin of hyperalgesic and hypoalgesic mice, respectively. Immunohistochemical labeling of spinal cord lamina I and II, dorsal root ganglion (DRG), and paw skin from hyperalgesic and hypoalgesic mice reveal increased and decreased TRPV1 expression, respectively. A role for TRPV1 in thermal DPN is further suggested by the failure of STZ treatment to influence thermal nociception in TRPV1 deficient mice. These findings demonstrate that altered TRPV1 expression and function contribute to diabetes-induced changes in thermal perception.
Appendix
Available only for authorised users
Literature
1.
Vinik AI, Park TS, Stansberry KB: Diabetic neuropathies. Diabetologia 2000, 43: 957–973. 10.1007/s001250051477CrossRefPubMed
2.
Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV: The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996, 2: 703–707. 10.1038/nm0696-703CrossRefPubMed
3.
Sugimoto K, Murakawa Y, Sima AA: Diabetic neuropathy a continuing enigma. Diabetes/Metabolism Res Rev 2000, 16: 408–433. Publisher Full Text 10.1002/1520-7560(200011/12)16:6%3C;408::AID-DMRR158%3E;3.0.CO;2-RCrossRef
4.
The diabetes control and complications trial research group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329: 977–986. 10.1056/NEJM199309303291401CrossRef
5.
Smith AG, Ramachandran P, Tripp S, Singleton ZR: Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001, 57: 1701–1704.CrossRefPubMed
6.
Gabra BH, Berthiaume N, Sirois P, Nantel F, Battistini B: The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy. Biol Chem 2006, 387: 127–143. 10.1515/BC.2006.018CrossRefPubMed
7.
Pierson CR, Zhang W, Murakawa Y, Sima AAF: Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy. J Neuropathol Exp Neurol 2003, 62: 260–271.PubMed
8.
Sima AAF: Diabetes underlies common neurological disorders. Ann Neurol 2004, 56: 459–461. 10.1002/ana.20249CrossRefPubMed
9.
Brussee V, Cunningham FA, Zochodne DW: Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004, 53: 1824–1830. 10.2337/diabetes.53.7.1824CrossRefPubMed
10.
11.
12.
Julius D, Basbaum AI: Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 2001, 97: 8134–8139.
13.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389: 816–824. 10.1038/39807CrossRefPubMed
14.
Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D: Bradykinin and nerve growth factor release the capsaicin receptor from Ptdlns (4,5) P2-Mediated inhibition. Nature 2001, 411: 957–962. 10.1038/35082088CrossRefPubMed
15.
Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V: An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002, 99: 8400–8405. 10.1073/pnas.122196999PubMedCentralCrossRefPubMed
16.
Van der Stelt M, Di Marzo V: Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem 2004, 271: 1827–1834. 10.1111/j.1432-1033.2004.04081.xCrossRefPubMed
17.
Lopshire JC, Nicol GD: The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons, whole-cell and single-channel studies. J Neurosci 1998, 18: 6081–6092.PubMed
18.
Moriyama T, Higashim T, Togashi K, Iida T, Segi E, Sugimoto Y, Tominaga T, Narumiya S, Tominaga M: Sensitization of TRPV1 by EP1and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 2005, 1: 3. 10.1186/1744-8069-1-3PubMedCentralCrossRefPubMed
19.
Cesare P, McNaughton P: A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc Natl Acad Sci USA 1996, 93: 15435–15439. 10.1073/pnas.93.26.15435PubMedCentralCrossRefPubMed
20.
Premkumar LS, Ahern GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000, 408: 985–990. 10.1038/35050121CrossRefPubMed
21.
Sugiura T, Tominaga M, Katsuya H, Mizumura K: Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol 2002, 88: 544–548.PubMed
22.
Hu HJ, Bhave G, Gereau RWT: Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J Neurosci 2002, 22: 7444–7452.PubMed
23.
Sugiura T, Bielefeldt K, Gebhart GF: TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation. J Neurosci 2004, 24: 9521–9530. 10.1523/JNEUROSCI.2639-04.2004CrossRef
24.
Kim BM, Lee SH, Shim WS, Oh U: Histamine-induced Ca2+influx via the PLA(2)/lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci Lett 2004, 361: 159–162. 10.1016/j.neulet.2004.01.019CrossRefPubMed
25.
Kress M, Guenther S: Role of [Ca2+]iin the ATP-induced heat sensitization process of rat nociceptive neurons. J Neurophysiol 1999, 81: 2612–2619.PubMed
26.
Tominaga M, Wada M, Masu M: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001, 98: 6951–6956. 10.1073/pnas.111025298PubMedCentralCrossRefPubMed
27.
Kwak J, Wang MH, Hwang SW, Kim TY, Lee SY, Oh U: Intracellular ATP increases capsaicin-activated channel activity by interacting with nucleotide-binding domains. J Neurosci 2000, 20: 8298–8304.PubMed
28.
Amadesi S, Nie J, Vergnolle N, Cottrell GS, Grady EF, Trevisani M, Manni C, Geppetti P, McRoberts JA, Ennes H, Davis JB, Mayer EA, Bunnett NWJ: Protease-Activated Receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004, 24: 4300–4312. 10.1523/JNEUROSCI.5679-03.2004CrossRefPubMed
29.
Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, Tominaga M, Noguchi K: Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004, 24: 4293–4299. 10.1523/JNEUROSCI.0454-04.2004CrossRefPubMed
30.
Shu Q, Mendell LM: Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 2001, 86: 2931–2938.PubMed
31.
Capsaicin Study Group: Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991, 151: 2225–2229. 10.1001/archinte.151.11.2225CrossRef
32.
Forst T, Pohlmann T, Kunt T, Goitom K, Schulz G, Lobig M, Engelbach M, Beyer J, Pfutzner A: The influence of local capsaicin treatment on small nerve fiber function and neurovascular control in symptomatic diabetic neuropathy. Acta Diabetologica 2002, 39: 1–6. 10.1007/s005920200005CrossRefPubMed
33.
Kamei J, Zushida K, Mortia K, Sasaki M, Tanaka S: Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur J Pharmacol 2001, 422: 83–86. 10.1016/S0014-2999(01)01059-7CrossRefPubMed
34.
Rashid MH, Ueda H: Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. J Pharmacol Exp Ther 2002, 303: 226–231. 10.1124/jpet.102.037952CrossRefPubMed
35.
Kirberg J, Berns A, von Boehmer H: Peripheral T Cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997, 186: 1269–1275. 10.1084/jem.186.8.1269PubMedCentralCrossRefPubMed
36.
Lo D, Freedman J, Hesse S, Palmiter RD, Brinster RL, Sherman LA: Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+and CD8+T cells. Eur J Immunol 1992, 22: 1013–1032. 10.1002/eji.1830220421CrossRefPubMed
37.
Smith SS, Patterson T, Pauza ME: Transgenic Ly-49A inhibits antigen-driven T cell activation and delays diabetes. J Immunol 2005, 174: 3897–3905.CrossRefPubMed
38.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288: 306–313. 10.1126/science.288.5464.306CrossRefPubMed
39.
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA, Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S, Randall A, Sheardown SA: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405: 183–187. 10.1038/35012076CrossRefPubMed
40.
Kamei U, Ohhashi Y, Aoki T, Kasuya Y: Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuli. Pharmacol Biochem Behav 1991, 39: 541–544. 10.1016/0091-3057(91)90224-PCrossRefPubMed
41.
Hong S, Wiley JW: Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J Biol Chem 2005, 280: 618–627.CrossRefPubMed
42.
Puntambekar P, Van Buren J, Raisinghani M, Premkumar LS, Ramkumar V: Direct interaction of adenosine with the TRPV1 channel protein. J Neurosci 2004, 24: 3663–3671. 10.1523/JNEUROSCI.4773-03.2004CrossRefPubMed
43.
Szallasi A, Blumberg PM, Annicelli LL, Krause JE, Cortright DN: The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 1999, 56: 581–587.PubMed
44.
Rashid MH, Inoue M, Kondo S, Kawashima T, Bakoshi S, Ueda H: Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 2003, 304: 940–948. 10.1124/jpet.102.046250CrossRefPubMed
45.
Kishi M, Tanabe J, Schmelzer JD, Low PA: Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002, 51: 819–824. 10.2337/diabetes.51.3.819CrossRefPubMed
46.
Sullivan KA, Feldman EL: New developments in diabetic neuropathy. Curr Opin Neurol 2005, 18: 586–590. 10.1097/01.wco.0000178825.56414.52CrossRefPubMed
47.
Pauza ME, Nguyen A, Wolfe T, Ho IC, Glimcher LH, Herrath MV, Lo D: Variable effects of transgenic c-maf on autoimmune diabetes. Diabetes 2001, 50: 39–46. 10.2337/diabetes.50.1.39CrossRefPubMed
48.
Kolta MG, Ngong JM, Rutledge LP, Pierzchala K, VanLoon GR: Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides 1996, 30: 335–344. 10.1016/S0143-4179(96)90022-0CrossRefPubMed
49.
Calcutt NA, Freshwater JD, Mizisin AP: Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004, 47: 718–724. 10.1007/s00125-004-1354-2CrossRefPubMed
50.
Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS: Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol Pain 2005, 1: 1–17. 10.1186/1744-8069-1-17CrossRef
51.
Schmeichel AM, Schmelzer JD, Low PA: Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003, 52: 165–171. 10.2337/diabetes.52.1.165CrossRefPubMed
52.
Suzukawa K, Miura K, Mitsushita J, Resau J, Hirose K, Crystal R, Kamata T: Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J Biol Chem 2000, 275: 175–178. 10.1074/jbc.275.18.13175CrossRef
53.
Pabbidi RM, Cao DS, Parihar A, Pauza ME, Premkumar LS: Direct role of streptozotocin in inducing thermal hyperalgesia by enhanced expression of TRPV1 in sensory neurons. Mol Pharmacol 2008, in press.
54.
Di Marzo V, Blumberg PM, Szallasi A: Endovanilloid signaling in pain. Curr Opin Neurobiol 2002, 12: 372–379. 10.1016/S0959-4388(02)00340-9CrossRefPubMed
55.
Ji R, Samad TA, Jin S, Schomll R, Woolf CJ: p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002, 36: 57–68. 10.1016/S0896-6273(02)00908-XCrossRefPubMed
56.
Eicheberg J: Protein kinase C changes in diabetes: is the concept relevant to neuropathy? Int Rev Neurobiol 2002, 50: 61–82.CrossRef
57.
Way KJ, Katai N, King GL: Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001, 18: 945–959. 10.1046/j.0742-3071.2001.00638.xCrossRefPubMed
58.
Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, Guo A, Blumberg PM, Szallasi A: Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000, 97: 3655–3660. 10.1073/pnas.060496197PubMedCentralCrossRefPubMed
59.
Sikand P, Premkumar LS: Potentiation of Glutamatergic Synaptic Transmission by Protein Kinase C Mediated Sensitization of TRPV1 at the First Sensory Synapse. J Physiol 2007, 2: 631–647. 10.1113/jphysiol.2006.118620CrossRef
60.
Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G, Mercuri NB: Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci 2003, 23: 3136–3144.PubMed
61.
Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti P, Bianchi A: Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 2001, 21: 1104–1109.PubMed
62.
Razavi R, Chan Y, Afifiyan FN, Liu XJ, Wan X, Yantha J, Tsui H, Tang L, Tsai S, Santamaria P, Driver JP, Serreze D, Salter MW, Dosch HD: TRPV1+Sensory Neurons Control β Cell Stress and Islet Inflammation in Autoimmune Diabetes. Cell 2006, 127: 1123–1135. 10.1016/j.cell.2006.10.038CrossRefPubMed
63.
Birder LA, Kanai AJ, De Groat WC, Kiss S, Nealen ML, Burke NE, Dineley KE, Watkins S, Reynolds IJ, Caterina MJ: Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001, 98: 13396–13401. 10.1073/pnas.231243698PubMedCentralCrossRefPubMed
64.
Birder LA, Nakamura Y, Kiss S, Nealen MI, Kanai AJ, Wang E, Ruiz G, De Groat WC, Apodaca G, Watkins S, Caterina MJ: Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nature 2002, 5: 856–860.
65.
66.
Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400: 452–457. 10.1038/22761CrossRefPubMed
67.
Premkumar LS, Raisinghani M: Nociceptors in cardiovascular functions: complex interplay as a result of cyclooxygenase inhibition. Mol Pain 2006, 2: 26. 10.1186/1744-8069-2-26PubMedCentralCrossRefPubMed
Metadata
Title
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity
Authors
Reddy M Pabbidi
Shuang-Quan Yu
Siying Peng
Romesh Khardori
Mary E Pauza
Louis S Premkumar
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2008
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-4-9

Other articles of this Issue 1/2008

Molecular Pain 1/2008 Go to the issue

Research

Nav1.7 expression is increased in painful human dental pulp

Research

The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant

Research

Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable

Review

Molecular and cellular limits to somatosensory specificity

Research

Anticipation of pain enhances the nociceptive transmission and functional connectivity within pain network in rats

Research

Long-term actions of interleukin-1β on delay and tonic firing neurons in rat superficial dorsal horn and their relevance to central sensitization